# AMLODIPINE AND OLMESARTAN MEDOXOMIL
> **ANDA207450** · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2017-05-15
## Drug
- **FDA Application Number:** ANDA207450
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMLODIPINE AND OLMESARTAN MEDOXOMIL
- **Generic name:** Amlodipine Besylate
- **Active ingredients:** AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** JUBILANT GENERICS
- **First approval:** 2017-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207450)
---
*AI Analytics · CC0 1.0*